ConductScience.org, home

Paper30952976

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

Barkovskaya A and 5 others. Sci Rep, 2019. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes. Papers, record 30952976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30952976

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.
PubMed
Journal
Sci Rep
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2021-01-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barkovskaya AAnna
2Seip KKotryna
3Hilmarsdottir BBylgja
4Maelandsmo GMGunhild M
5Moestue SASiver A
6Itkonen HMHarri Mhttps://orcid.org/0000-0002-5194-7064

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
N-AcetylglucosaminyltransferasesMajor topic
Triple Negative Breast NeoplasmsMajor topic
Apoptosis
Cell Cycle Checkpoints
Cell Line, Tumor
DNA Damage
Female
Humans
Transcription Factor HES-1
Up-Regulation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
R01 GM094263NIGMS NIH HHSUnited StatesR01GM094263PubMed and NIHNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121840999Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes.J Biol Chem2011https://conductscience.org/library/papers/21840999PubMed
216964247Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.Nat Cell Biol2006https://conductscience.org/library/papers/16964247PubMed
325636967mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.Mol Cancer Res2015https://conductscience.org/library/papers/25636967PubMed
429496446Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/29496446PubMed
529127647O-GlcNAcylation in women's cancers: breast, endometrial and ovarian.J Bioenerg Biomembr2018https://conductscience.org/library/papers/29127647PubMed
621760855Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.Horm Cancer2011https://conductscience.org/library/papers/21760855PubMed
726614871Ribosomal Protein S6 Phosphorylation: Four Decades of Research.Int Rev Cell Mol Biol2015https://conductscience.org/library/papers/26614871PubMed
828408472The sweet side of the cell cycle.Biochem Soc Trans2017https://conductscience.org/library/papers/28408472PubMed
927458206OGT restrains the expansion of DNA damage signaling.Nucleic Acids Res2016https://conductscience.org/library/papers/27458206PubMed
108999954A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine.J Biol Chem1997https://conductscience.org/library/papers/8999954PubMed
1118398844How basal are triple-negative breast cancers?Int J Cancer2008https://conductscience.org/library/papers/18398844PubMed
1229556333Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer as a Prognosis Marker and Therapy Target via the AKT Pathway and EMT Process.J Cancer2018https://conductscience.org/library/papers/29556333PubMed
1318550849HES1 is a novel interactor of the Fanconi anemia core complex.Blood2008https://conductscience.org/library/papers/18550849PubMed
1420190804Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.Oncogene2010https://conductscience.org/library/papers/20190804PubMed
1512101391Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update.Apoptosis2002https://conductscience.org/library/papers/12101391PubMed
1622234518Molecular insights on basal-like breast cancer.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22234518PubMed
179218810Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.EMBO J1997https://conductscience.org/library/papers/9218810PubMed
1821176168PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration.Cell Commun Signal2010https://conductscience.org/library/papers/21176168PubMed
1928929346O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.Horm Cancer2018https://conductscience.org/library/papers/28929346PubMed
2023935944O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.PLoS One2013https://conductscience.org/library/papers/23935944PubMed

See all 49 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42120876Identification and quantification of intracellular N-acetylglucosamine modified glycoRNAs.Nat Commun2026https://conductscience.org/library/papers/42120876PubMed
40824482Cell cycle regulation in cancer cells by O-GlcNAcylation.Glycoconj J2025https://conductscience.org/library/papers/40824482PubMed
40392313HES1 in cancer: a key player in tumorigenesis and its prognostic significance.Mol Genet Genomics2025https://conductscience.org/library/papers/40392313PubMed
40128346O-GlcNAcylation on serine 40 of histone H2A promotes proliferation and invasion in triple-negative breast cancer.Sci Rep2025https://conductscience.org/library/papers/40128346PubMed
39413067The correlation between cellular O-GlcNAcylation and sensitivity to O-GlcNAc inhibitor in colorectal cancer cells.PLoS One2024https://conductscience.org/library/papers/39413067PubMed
39337387O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39337387PubMed
38642246Breast cancer therapy: from the perspective of glucose metabolism and glycosylation.Mol Biol Rep2024https://conductscience.org/library/papers/38642246PubMed
37231419Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.Cancer Cell Int2023https://conductscience.org/library/papers/37231419PubMed
36291918The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36291918PubMed
36059648Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies.Front Oncol2022https://conductscience.org/library/papers/36059648PubMed
36039850Suppression of Ca2+ signaling enhances melanoma progression.EMBO J2022https://conductscience.org/library/papers/36039850PubMed
35216622Unconventional protein post-translational modifications: the helmsmen in breast cancer.Cell Biosci2022https://conductscience.org/library/papers/35216622PubMed
34014546Diabetes and Cancer: The Epidemiological and Metabolic Associations.Adv Exp Med Biol2021https://conductscience.org/library/papers/34014546PubMed
33669699Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.J Cardiovasc Dev Dis2021https://conductscience.org/library/papers/33669699PubMed
33669256Overview of the Assays to Probe O-Linked β-N-Acetylglucosamine Transferase Binding and Activity.Molecules2021https://conductscience.org/library/papers/33669256PubMed
33159661O-GlcNAcylation: the "stress and nutrition receptor" in cell stress response.Cell Stress Chaperones2021https://conductscience.org/library/papers/33159661PubMed
33046784Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.Sci Rep2020https://conductscience.org/library/papers/33046784PubMed
32611550Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.Mol Cancer Res2020https://conductscience.org/library/papers/32611550PubMed
31813458The Metabolic Interplay between Cancer and Other Diseases.Trends Cancer2019https://conductscience.org/library/papers/31813458PubMed
31426393Epigenetic Dysregulation at the Crossroad of Women's Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31426393PubMed

Download CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
BLNK29760PubTator's text mininghttps://conductscience.org/library/genes/29760NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
DNTT1791PubTator's text mininghttps://conductscience.org/library/genes/1791NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
HES13280PubTator's text mininghttps://conductscience.org/library/genes/3280NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
NOTCH14851PubTator's text mininghttps://conductscience.org/library/genes/4851NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
OGA10724PubTator's text mininghttps://conductscience.org/library/genes/10724NCBI Gene
OGT8473PubTator's text mininghttps://conductscience.org/library/genes/8473NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
RPS66194PubTator's text mininghttps://conductscience.org/library/genes/6194NCBI Gene
TAS2R63P338413PubTator's text mininghttps://conductscience.org/library/genes/338413NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30952976

GET https://conductscience.org/api/papers/v1/30952976/references?page=2